This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Should You Buy Si-Bone (SIBN) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SIBNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tempus AI: Revenue Mix and 2026 Growth Outlook Explained
by Urmimala Biswas
Tempus AI's balanced genomics and data engine is scaling fast as profitability metrics improve and 2026 revenue targets approach the billion-plus mark.
EXASPositive Net Change GHNegative Net Change TEMNegative Net Change
healthcare medical medical-devices oncology-screening
COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises
by Zacks Equity Research
COO jumps after Q4 earnings and sales top estimates, powered by rising MyDay demand and strong MiSight momentum.
ISRGNegative Net Change COONegative Net Change MEDPPositive Net Change SGHTNegative Net Change
earnings medical medical-devices
Here's Why You Should Add Inogen Stock to Your Portfolio Now
by Zacks Equity Research
INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.
ISRGNegative Net Change INGNNegative Net Change MEDPPositive Net Change SGHTNegative Net Change
medical medical-devices
MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System
by Zacks Equity Research
Medtronic gains from the FDA clearance of its Hugo RAS system, expanding U.S. access to robotic-assisted urologic surgery.
MDTNegative Net Change OMCLNegative Net Change ILMNNegative Net Change BTSGNegative Net Change
medical medical-devices
HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency
by Zacks Equity Research
Hims & Hers is set to acquire YourBio Health, adding bladeless microneedle tech to transform the blood collection experience.
ISRGNegative Net Change IDXXNo Net Change HIMSNegative Net Change SOLVNegative Net Change
medical medical-devices
HealthEquity Stock Gains as Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
HQY stock gains post Q3 results as earnings and revenue top estimates, supported by rising HSAs and stronger margins.
BSXNegative Net Change ISRGNegative Net Change HQYNegative Net Change MEDPPositive Net Change
earnings medical medical-devices
GEHC and Mayo Clinic Launch GEMINI-RT to Aid Personalized Cancer Care
by Zacks Equity Research
GE HealthCare and Mayo Clinic unveil GEMINI-RT, which is likely to blend imaging, AI and monitoring to advance personalized cancer care.
BSXNegative Net Change ISRGNegative Net Change MEDPPositive Net Change GEHCNegative Net Change
medical medical-devices
Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions
by Moumi Mondal
HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.
BDXNegative Net Change MDTNegative Net Change HOLXNegative Net Change
medical medical-devices
Here's Why You Should Add CONMED Stock to Your Portfolio Now
by Zacks Equity Research
CONMED gains momentum from high-margin platforms and supply-chain recovery, even as tariffs and dV5 adoption weigh on near-term margins.
CNMDNegative Net Change ISRGNegative Net Change IDXXNo Net Change PODDNegative Net Change
medical medical-devices
Margins Face Tariff Pressure: Is ISRG's Profitability at Risk?
by Indrajit Bandyopadhyay
Intuitive Surgical's strong growth contrasts with tariff-driven margin pressure, raising questions about its ability to hold gross margins near 67%.
MDTNegative Net Change SYKPositive Net Change ISRGNegative Net Change
medical medical-devices
Cooper Companies to Post Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
COO is set to post Q4 earnings as MyDAY momentum offsets Clariti and APAC softness, with revenues and earnings expected to rise.
EWPositive Net Change HOLXNegative Net Change DXCMNegative Net Change COONegative Net Change
medical medical-devices
Hims & Hers Expands Care Scope as Prescription Platforms Evolve
by Debanjana Dey
HIMS grows its telehealth-to-prescription model with new offerings in weight loss, hormone care and diagnostics.
AMWLNo Net Change HIMSNegative Net Change LFMDNo Net Change
medical medical-devices
After Golden Cross, Assured Guaranty (AGO)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AGOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Continue to Hold RMD Stock in Your Portfolio?
by Zacks Equity Research
Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.
BSXNegative Net Change MDTNegative Net Change RMDNegative Net Change GMEDPositive Net Change
medical medical-devices
The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock
by Zacks Equity Research
Medtronic begins the U.S. rollout of MiniMed 780G with Abbott's Instinct sensor, advancing diabetes care.
ABTNegative Net Change BSXNegative Net Change MDTNegative Net Change GMEDPositive Net Change
medical medical-devices
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
by Zacks Equity Research
ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.
BSXNegative Net Change ECLPositive Net Change ISRGNegative Net Change MEDPPositive Net Change
medical medical-devices
GEHC Unveils Allia Moveo to Elevate Mobility in Interventional Care
by Zacks Equity Research
GE HealthCare launches Allia Moveo with a cable-free C-arm and AI tools, aiming to elevate mobility, access and workflow in interventional care.
BSXNegative Net Change ISRGNegative Net Change MEDPPositive Net Change GEHCNegative Net Change
medical medical-devices
Are Options Traders Betting on a Big Move in BrainsWay Stock?
by Zacks Equity Research
Investors need to pay close attention to BrainsWay stock based on the movements in the options market lately.
BWAYNegative Net Change
medical medical-devices
Simulations Plus' Q4 Earnings & Sales Meet Estimates, Fall Y/Y
by Zacks Equity Research
SLP posts softer fiscal Q4 2025 results but meets full-year goals as cloud, AI and integrated workflows shape its next growth phase.
SAPPositive Net Change SLPNegative Net Change BLKBNegative Net Change CDNSNegative Net Change
computers earnings medical medical-devices tech-stocks
Baxter Issues Recall Notice for Permanent Removal of Life2000 Ventilation
by Zacks Equity Research
Baxter recalls its Life2000 ventilation system over a serious cybersecurity flaw, pulling the device from the market despite no reported injuries.
BSXNegative Net Change BAXNo Net Change CAHPositive Net Change IDXXNo Net Change
medical medical-devices
M&A Strategy Strengthens Boston Scientific's Growth Prospects
by Moumi Mondal
BSX accelerates growth as a wave of acquisitions boosts core portfolios and fuels expansion into high-growth adjacent markets.
BSXNegative Net Change TFXNegative Net Change GEHCNegative Net Change
medical medical-devices
Should You Continue to Hold LH Stock in Your Portfolio?
by Zacks Equity Research
Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.
BSXNegative Net Change LHNegative Net Change MDTNegative Net Change GMEDPositive Net Change
medical medical-devices
GE HealthCare Unveils Next-Gen SIGNA MRI Systems to Elevate Efficiency
by Zacks Equity Research
GEHC's new SIGNA MRI lineup debuts AI-driven speed, sustainable design and advanced imaging aimed at boosting productivity.
BSXNegative Net Change ISRGNegative Net Change MEDPPositive Net Change GEHCNegative Net Change
medical medical-devices
Business First (BFST) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
BFSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines